KX2-391
KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.
Product Specifications
CAS Number
897016-82-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
431.53
Molecular Formula
C26H29N3O3
Notes
Research use only, not for human use.
Receptor
Src (Hep 3B) | Src (Hep G2) | Src (HuH7) | Src (PLC/PRF/5)
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog